• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将依赖作为定义阿尔茨海默病严重程度的统一结构。

Dependence as a unifying construct in defining Alzheimer's disease severity.

机构信息

Janssen Alzheimer Immunotherapy Research & Development, South San Francisco, CA, USA.

出版信息

Alzheimers Dement. 2010 Nov;6(6):482-93. doi: 10.1016/j.jalz.2009.09.004.

DOI:10.1016/j.jalz.2009.09.004
PMID:21044778
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3884683/
Abstract

This article reviews measures of Alzheimer's disease (AD) progression in relation to patient dependence and offers a unifying conceptual framework for dependence in AD. Clinicians typically characterize AD by symptomatic impairments in three domains: cognition, function, and behavior. From a patient's perspective, changes in these domains, individually and in concert, ultimately lead to increased dependence and loss of autonomy. Examples of dependence in AD range from a need for reminders (early AD) to requiring safety supervision and assistance with basic functions (late AD). Published literature has focused on the clinical domains as somewhat separate constructs and has given limited attention to the concept of patient dependence as a descriptor of AD progression. This article presents the concept of dependence on others for care needs as a potential method for translating the effect of changes in cognition, function, and behavior into a more holistic, transparent description of AD progression.

摘要

本文综述了与患者依赖相关的阿尔茨海默病(AD)进展的衡量标准,并为 AD 中的依赖提供了一个统一的概念框架。临床医生通常通过认知、功能和行为三个领域的症状损害来描述 AD。从患者的角度来看,这些领域的变化(单独或协同)最终会导致依赖性增加和自主能力丧失。AD 中的依赖的例子包括需要提醒(早期 AD)到需要安全监督和基本功能协助(晚期 AD)。已发表的文献主要关注临床领域,将其视为相对独立的结构,而对患者依赖作为 AD 进展描述符的概念关注较少。本文提出了依赖他人满足护理需求的概念,作为将认知、功能和行为变化的影响转化为更全面、更透明的 AD 进展描述的一种潜在方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ab7/3884683/87eac080761f/nihms-352646-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ab7/3884683/1901afa7bc81/nihms-352646-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ab7/3884683/87eac080761f/nihms-352646-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ab7/3884683/1901afa7bc81/nihms-352646-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ab7/3884683/87eac080761f/nihms-352646-f0002.jpg

相似文献

1
Dependence as a unifying construct in defining Alzheimer's disease severity.将依赖作为定义阿尔茨海默病严重程度的统一结构。
Alzheimers Dement. 2010 Nov;6(6):482-93. doi: 10.1016/j.jalz.2009.09.004.
2
The validity of dependence as a health outcome measure in Alzheimer's disease.依赖作为阿尔茨海默病健康结局测量指标的有效性。
Am J Alzheimers Dis Other Demen. 2013 May;28(3):245-52. doi: 10.1177/1533317513481092. Epub 2013 Mar 19.
3
The relationship between changes in quality of life outcomes and progression of Alzheimer's disease: results from the dependence in AD in England 2 longitudinal study.阿尔茨海默病生活质量结果变化与疾病进展之间的关系:来自英国AD依赖性2纵向研究的结果
Int J Geriatr Psychiatry. 2015 Apr;30(4):400-8. doi: 10.1002/gps.4150. Epub 2014 Jun 12.
4
Dependence Levels as Interim Clinical Milestones Along the Continuum of Alzheimer's Disease: 18-Month Results from the GERAS Observational Study.阿尔茨海默病连续体中的依赖程度作为临时临床里程碑:来自 GERAS 观察性研究的 18 个月结果。
J Prev Alzheimers Dis. 2017;4(2):72-80. doi: 10.14283/jpad.2017.2.
5
Quality of Life and Utility Measurement in a Large Clinical Trial Sample of Patients with Mild to Moderate Alzheimer's Disease: Determinants and Level of Changes Observed.轻度至中度阿尔茨海默病患者大型临床试验样本中的生活质量与效用测量:观察到的决定因素及变化水平
Value Health. 2015 Jul;18(5):638-45. doi: 10.1016/j.jval.2015.03.1787. Epub 2015 Apr 10.
6
A path analysis of patient dependence and caregiver burden in Alzheimer's disease.阿尔茨海默病患者依赖与照料者负担的路径分析
Int Psychogeriatr. 2016 Jul;28(7):1133-41. doi: 10.1017/S1041610216000223. Epub 2016 Mar 1.
7
Qualitative research and literature review support the integrated Alzheimer's Disease Rating Scale (iADRS) content validity in early symptomatic AD.定性研究和文献综述支持综合阿尔茨海默病评定量表(iADRS)在早期症状性阿尔茨海默病中的内容效度。
J Prev Alzheimers Dis. 2025 Apr;12(4):100101. doi: 10.1016/j.tjpad.2025.100101. Epub 2025 Mar 4.
8
Bridging from clinical endpoints to estimates of treatment value for external decision makers.从临床终点到为外部决策者评估治疗价值的桥梁搭建。
J Nutr Health Aging. 2009 Mar;13(3):256-9. doi: 10.1007/s12603-009-0068-z.
9
Dependence in Alzheimer's disease and service use costs, quality of life, and caregiver burden: the DADE study.阿尔茨海默病的依赖与服务利用成本、生活质量和照护者负担:DADE 研究。
Alzheimers Dement. 2015 Mar;11(3):280-90. doi: 10.1016/j.jalz.2014.03.001. Epub 2014 Jul 26.
10
[Awareness of deficits and anosognosia in Alzheimer's disease].[阿尔茨海默病中的缺陷认知与疾病感缺失]
Encephale. 2004 Nov-Dec;30(6):570-7. doi: 10.1016/s0013-7006(04)95472-3.

引用本文的文献

1
The Alzheimer's Disease Cooperative Study - Activities of Daily Living dependence score: revision and validation of an algorithm evaluating patient dependence across the spectrum of AD severity.阿尔茨海默病协作研究 - 日常生活活动依赖评分:评估阿尔茨海默病严重程度全谱患者依赖程度的算法的修订与验证
J Prev Alzheimers Dis. 2025 Sep;12(8):100261. doi: 10.1016/j.tjpad.2025.100261. Epub 2025 Jul 1.
2
The Role of Social Support for Depressive Symptoms in Dementia: A Four-Year Longitudinal Study.社会支持对痴呆症患者抑郁症状的作用:一项为期四年的纵向研究。
Innov Aging. 2025 Jul 1;9(6):igaf047. doi: 10.1093/geroni/igaf047. eCollection 2025.
3

本文引用的文献

1
Forecasting the global burden of Alzheimer's disease.预测阿尔茨海默病的全球负担。
Alzheimers Dement. 2007 Jul;3(3):186-91. doi: 10.1016/j.jalz.2007.04.381.
2
Commentary on "Health economics and the value of therapy in Alzheimer's disease." Quality of life in dementia: development and use of a disease-specific measure of health-related quality of life in dementia.
Alzheimers Dement. 2007 Jul;3(3):166-71. doi: 10.1016/j.jalz.2007.04.384.
3
Decision analytic models for Alzheimer's disease: state of the art and future directions.阿尔茨海默病的决策分析模型:现状与未来方向
General practitioner and practice nurses perspectives on implementation of the 75+ health assessment: Implications for dementia care and well-being.
全科医生和执业护士对75岁以上健康评估实施情况的看法:对痴呆症护理和福祉的影响
J Adv Nurs. 2025 Mar;81(3):1505-1516. doi: 10.1111/jan.16354. Epub 2024 Jul 29.
4
Facilitators and barriers of help-seeking for persons with dementia in Asia-findings from a qualitative study of informal caregivers.亚洲痴呆症患者寻求帮助的促进因素和障碍:一项对非正式照护者的定性研究结果。
Front Public Health. 2024 Jul 12;12:1396056. doi: 10.3389/fpubh.2024.1396056. eCollection 2024.
5
Resilience in caregivers of people with mild-to-moderate dementia: findings from the IDEAL cohort.轻度至中度痴呆症患者照顾者的韧性:来自 IDEAL 队列的研究结果。
BMC Geriatr. 2023 Dec 5;23(1):804. doi: 10.1186/s12877-023-04549-y.
6
Trajectories of cognitive and perceived functional decline in people with dementia: Findings from the IDEAL programme.痴呆症患者认知和感知功能下降的轨迹:来自 IDEAL 计划的研究结果。
Alzheimers Dement. 2024 Jan;20(1):410-420. doi: 10.1002/alz.13448. Epub 2023 Sep 2.
7
Move Your Body toward Healthy Aging: Potential Neuroprotective Mechanisms of Irisin in Alzheimer's Disease.让身体动起来,健康老龄化:鸢尾素在阿尔茨海默病中的潜在神经保护机制。
Int J Mol Sci. 2023 Aug 4;24(15):12440. doi: 10.3390/ijms241512440.
8
Validation of the German Montreal-Cognitive-Assessment-H for hearing-impaired.针对听力受损者的德语版蒙特利尔认知评估量表-H的验证
Front Aging Neurosci. 2023 Jul 19;15:1209385. doi: 10.3389/fnagi.2023.1209385. eCollection 2023.
9
Cognitive rehabilitation for people with mild to moderate dementia.轻度至中度痴呆患者的认知康复。
Cochrane Database Syst Rev. 2023 Jun 29;6(6):CD013388. doi: 10.1002/14651858.CD013388.pub2.
10
Rural-urban disparities in preventive breast and cervical cancer screening among women with early-onset dementia.农村-城市地区在早期发病痴呆女性中预防乳腺癌和宫颈癌筛查方面的差异。
BMC Womens Health. 2023 May 11;23(1):255. doi: 10.1186/s12905-023-02301-7.
Alzheimers Dement. 2008 May;4(3):212-22. doi: 10.1016/j.jalz.2008.02.003.
4
Caregivers' assessments of preference-based quality of life in Alzheimer's disease.照顾者对阿尔茨海默病基于偏好的生活质量的评估。
Alzheimers Dement. 2008 May;4(3):203-11. doi: 10.1016/j.jalz.2007.11.018. Epub 2008 Apr 24.
5
National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness- Alzheimer's Disease (CATIE-AD): baseline characteristics.美国国立精神卫生研究所抗精神病药物干预有效性临床试验 - 阿尔茨海默病(CATIE - AD):基线特征
Curr Alzheimer Res. 2007 Jul;4(3):325-35. doi: 10.2174/156720507781077214.
6
Cost effectiveness of memantine in moderately severe to severe Alzheimer's disease : a markov model in Finland.美金刚治疗中重度至重度阿尔茨海默病的成本效果:芬兰的马尔可夫模型。
Clin Drug Investig. 2004;24(7):373-84. doi: 10.2165/00044011-200424070-00001.
7
Evaluated need, costs of care, and payer perspective in degenerative dementia patients cared for in the United States.美国退行性痴呆患者的评估需求、护理成本及支付方视角
Alzheimer Dis Assoc Disord. 2007 Jan-Mar;21(1):39-48. doi: 10.1097/WAD.0b013e31802f2426.
8
A systematic review of assessment and treatment of moderate to severe Alzheimer's disease.中度至重度阿尔茨海默病评估与治疗的系统评价
Prim Care Companion J Clin Psychiatry. 2006;8(3):158-9. doi: 10.4088/pcc.v08n0306.
9
Functional impairment, healthcare costs and the prevalence of institutionalisation in patients with Alzheimer's disease and other dementias.阿尔茨海默病及其他痴呆症患者的功能障碍、医疗费用与机构化患病率
Pharmacoeconomics. 2006;24(3):265-80. doi: 10.2165/00019053-200624030-00006.
10
The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease.多奈哌齐、卡巴拉汀、加兰他敏和美金刚用于治疗阿尔茨海默病的临床疗效及成本效益
Health Technol Assess. 2006 Jan;10(1):iii-iv, ix-xi, 1-160. doi: 10.3310/hta10010.